The upside down world of diabetes care medical economics and what we might do to improve it.

Irl B Hirsch, David M Harlan

Journal: Current opinion in endocrinology, diabetes, and obesity 2018;24(2):112-118

PMID: 28099208

Abstract

PURPOSE OF REVIEW

Increasingly over the past generation, the American healthcare delivery system has received consistently poor marks with regard to public health outcomes and costs. This review by two seasoned diabetes care providers is intended to shed light on the fundamental flaws we believe to underlie that poor performance, and suggest options for better outcomes and cost efficiencies.

RECENT FINDINGS

Despite major advances in diabetes management medications and tools, overall public health with regard to diabetes outcomes remains poor. Efforts focused on controlling costs appear to be exacerbating the problem.

SUMMARY

For chronic diseases like diabetes, fee-for-service care models are fundamentally flawed and predictably fail. We suggest that a major overhaul of the medical economics underlying diabetes care can improve patient outcomes and decrease costs.

Address: aDepartment of Medicine, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, Massachusetts bDepartment of Medicine, Division of Metabolism, Endocrinology, and Nutrition at the University of Washington Medical School, Seattle, Washington, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.